Perdaman Pharmaceuticals Private Limited

Pharmaceutical company manufacturing a variety of drugs and exporting them globally.

2008 | Delhi (India) | Active
Last Updated:

Perdaman Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 15.00 Cr
  • Paid Up Capital ₹ 12.03 Cr
  • Company Age 17 Year, 8 Days
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth 5.20%
  • Profit Growth 18.89%
  • Ebitda 32.32%
  • Net Worth 3.20%
  • Total Assets 30.08%

About Perdaman Pharmaceuticals

Perdaman Pharmaceuticals Private Limited (PPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 March 2008 and has a history of 17 years. Its registered office is in Delhi, India.

The Corporate was formerly known as Perdaman Financial Services And Holdings Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 12.03 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Perdaman Pharmaceuticals Private Limited India is Shubham Namdev as COMPANY SECRETARY. Vikas Rambal, Sarojni Rambal, Manoj Rambal, and Two other members serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24233DL2008PTC174864

  • Company No.

    174864

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    04 Mar 2008

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma
Company report

Perdaman Pharmaceuticals Private Limited

Explore comprehensive data for Perdaman Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Perdaman Pharmaceuticals?

Executive Team (1)

NameDesignationAppointment DateStatus
Shubham Namdev Company Secretary20-Dec-2022Current

Board Members (5)

NameDesignationAppointment DateStatus
Vikas Rambal Country flag representing In Director 04-Mar-2008Current
Sarojni Rambal Country flag representing In Director 04-Mar-2008Current
Manoj Rambal Country flag representing In Director 15-May-2010Current
Usha Rambal Country flag representing In Director 14-Oct-2010Current
Samir Garud Country flag representing In Director 20-Jun-2013Current

Financial Performance of Perdaman Pharmaceuticals.

Perdaman Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.2% increase. The company also saw a substantial improvement in profitability, with a 18.89% increase in profit. The company's net worth moved up by a moderate rise of 3.2%.

Perdaman Pharmaceuticals revenue growth over time
Perdaman Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
5.20%
Revenue from Operations
5.33%
Total Assets
30.08%
Profit or Loss
18.89%
Net Worth
3.20%
EBITDA
32.32%

What is the Ownership and Shareholding Structure of Perdaman Pharmaceuticals?

In 2023, Perdaman Pharmaceuticals had a public holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Perdaman Pharmaceuticals?

Unlock and access historical data on people associated with Perdaman Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Perdaman Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Perdaman Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Perdaman Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Perdaman Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Perdaman Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Perdaman Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

  • Director Appointment

    Samir Madhukar Garud was appointed as a Director was appointed as a Director on 20 Jun 2013 & has been associated with this company since 11 years 8 months .

  • Director Appointment

    Usha Rambal was appointed as a Director was appointed as a Director on 14 Oct 2010 & has been associated with this company since 14 years 4 months .

  • Director Appointment

    Manoj Kumar Rambal was appointed as a Director was appointed as a Director on 15 May 2010 & has been associated with this company since 14 years 9 months .

  • Director Appointment

    Vikas Rambal was appointed as a Director was appointed as a Director on 04 Mar 2008 & has been associated with this company since 17 years 8 days .

Frequently asked questions

  • What is the Incorporation or founding date of Perdaman Pharmaceuticals Private Limited?

    Perdaman Pharmaceuticals Private Limited was incorporated on 04 Mar 2008.

  • What is authorized share capital and paid-up capital of Perdaman Pharmaceuticals Private Limited?

    The authorized share capital of Perdaman Pharmaceuticals Private Limited is ₹ 15.00 Cr and paid-up capital is ₹ 12.03 Cr.

  • Who are the current board members & directors of Perdaman Pharmaceuticals Private Limited?

    Currently 6 directors are associated with Perdaman Pharmaceuticals Private Limited.

    • Vikas Rambal
    • Sarojni Rambal
    • Manoj Kumar Rambal
    • Usha Rambal
    • Samir Madhukar Garud
    • Shubham Kumar Namdev

  • What is the registered address of Perdaman Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Perdaman Pharmaceuticals Private Limited is N-9, Ground Floor Panchsheel Park India, New Delhi, 110017.

  • What is the corporate identification number (CIN) and company number of Perdaman Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Perdaman Pharmaceuticals Private Limited is U24233DL2008PTC174864 and the company number is 174864 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Perdaman Pharmaceuticals Private Limited?

    The Official website of Perdaman Pharmaceuticals Private Limited is https://www.perdaman.com.au

  • What has been the recent revenue trend for Perdaman Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Perdaman Pharmaceuticals Private Limited has risen by 5.20%.

  • What change has been observed in the net worth of Perdaman Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Perdaman Pharmaceuticals Private Limited has experienced an upsurge of 3.20%.

  • When was the last Balance Sheet of Perdaman Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Perdaman Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed